SRTD Biotech is a German biotechnology company developing next-generation precision mRNA therapeutics. Its proprietary technology enables cell-specific mRNA expression by leveraging intracellular disease markers to selectively activate therapeutic payloads within target cells, while minimizing exposure in healthy tissue. The company is advancing a pipeline of novel targeted RNA therapies across oncology, autoimmune diseases and fibrosis.
Venture Capital
Current
Europe
Seed
Diagnostic & Therapeutic Platforms
2026
Status
Creation Date
Investment Date
Fund Name